Fine-tuning adoptive cell therapy for advanced cancers
Friday, July 24, 2020 - 14:41
in Health & Medicine
Researchers identified a discordant phenomenon in which a subset of patients displayed profoundly decreased expression of the transgenic TCR over time, despite the transgenic TCR being present at the DNA level.